0001036044falseQ2--12-31http://fasb.org/srt/2024#ChiefExecutiveOfficerMemberP1Y0001036044inve:SeriesBConvertiblePreferredStockMemberus-gaap:PreferredStockMember2024-03-3100010360442023-12-310001036044us-gaap:CommonStockMember2024-04-012024-06-300001036044us-gaap:SegmentContinuingOperationsMemberinve:StockOptionsAndRestrictedStockUnitsMember2025-01-012025-06-300001036044us-gaap:TreasuryStockCommonMember2024-12-3100010360442024-12-310001036044us-gaap:PreferredStockMemberinve:SeriesBConvertiblePreferredStockMember2024-06-300001036044us-gaap:RestrictedStockUnitsRSUMember2024-01-012024-06-300001036044us-gaap:EmployeeStockMember2025-06-300001036044us-gaap:FairValueMeasurementsNonrecurringMember2025-06-300001036044us-gaap:RestrictedStockUnitsRSUMemberinve:StockRepurchaseProgramMember2025-01-012025-06-300001036044srt:AsiaPacificMember2025-01-012025-06-300001036044inve:VacatedProductionSpaceMember2025-01-012025-06-300001036044us-gaap:CommonStockMember2025-01-012025-06-300001036044srt:MinimumMember2025-06-300001036044inve:StockOptionsAndRestrictedStockUnitsMemberus-gaap:ResearchAndDevelopmentExpenseMember2024-04-012024-06-300001036044inve:CommonStockIssuableUponConversionOfSeriesBConvertiblePreferredStockMember2024-01-012024-06-3000010360442025-04-012025-06-300001036044us-gaap:FurnitureAndFixturesMember2024-12-3100010360442024-04-012024-06-300001036044us-gaap:CommonStockMember2025-03-310001036044us-gaap:RetainedEarningsMember2024-04-012024-06-3000010360442024-01-012024-12-310001036044srt:AsiaPacificMember2024-01-012024-06-300001036044us-gaap:SegmentContinuingOperationsMemberinve:StockOptionsAndRestrictedStockUnitsMember2024-04-012024-06-300001036044inve:StockOptionsAndRestrictedStockUnitsMemberus-gaap:SellingAndMarketingExpenseMember2025-04-012025-06-300001036044us-gaap:GeneralAndAdministrativeExpenseMemberinve:StockOptionsAndRestrictedStockUnitsMember2025-01-012025-06-300001036044us-gaap:RestrictedStockUnitsRSUMember2024-04-012024-06-300001036044us-gaap:RetainedEarningsMember2024-12-310001036044inve:StockOptionsAndRestrictedStockUnitsMemberus-gaap:SellingAndMarketingExpenseMember2025-01-012025-06-300001036044us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsNonrecurringMember2024-12-310001036044inve:EuropeAndMiddleEastMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMember2024-04-012024-06-300001036044us-gaap:RestrictedStockUnitsRSUMember2025-01-012025-06-300001036044us-gaap:RevenueFromContractWithCustomerMembersrt:AsiaPacificMemberus-gaap:GeographicConcentrationRiskMember2025-04-012025-06-300001036044inve:EuropeAndMiddleEastMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMember2025-04-012025-06-300001036044inve:PhysicalSecurityBusinessMember2024-09-062024-09-060001036044us-gaap:RevenueFromContractWithCustomerMembersrt:AsiaPacificMemberus-gaap:GeographicConcentrationRiskMember2024-01-012024-06-3000010360442025-01-012025-06-300001036044srt:AmericasMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMember2025-01-012025-06-300001036044us-gaap:CommonStockMemberinve:SeriesBConvertiblePreferredStockMember2025-06-300001036044inve:CommonStockIssuableUponConversionOfSeriesBConvertiblePreferredStockMember2025-04-012025-06-300001036044us-gaap:EmployeeStockOptionMember2024-04-012024-06-300001036044us-gaap:EmployeeSeveranceMember2025-04-012025-06-300001036044inve:StockOptionsAndRestrictedStockUnitsMember2025-04-012025-06-300001036044us-gaap:RetainedEarningsMember2025-06-300001036044us-gaap:AdditionalPaidInCapitalMember2024-04-012024-06-300001036044inve:PlantAndMachineryMember2024-12-310001036044inve:StockOptionsAndRestrictedStockUnitsMemberus-gaap:CostOfSalesMember2024-01-012024-06-300001036044us-gaap:RevenueFromContractWithCustomerMembersrt:AsiaPacificMemberus-gaap:GeographicConcentrationRiskMember2024-04-012024-06-300001036044us-gaap:AdditionalPaidInCapitalMember2025-01-012025-06-300001036044inve:StockOptionsAndRestrictedStockUnitsMemberus-gaap:CostOfSalesMember2025-01-012025-06-300001036044us-gaap:USTreasurySecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2025-06-300001036044srt:AmericasMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMember2025-04-012025-06-300001036044inve:StockRepurchaseProgramMember2025-06-302025-06-300001036044inve:EuropeAndMiddleEastMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMember2024-01-012024-06-300001036044us-gaap:RetainedEarningsMember2024-03-310001036044inve:PerformanceStockUnitsPsuMember2024-04-012024-06-300001036044us-gaap:RetainedEarningsMember2024-06-300001036044us-gaap:AdditionalPaidInCapitalMember2024-06-3000010360442024-01-012024-09-300001036044inve:SeriesBConvertiblePreferredStockMember2025-03-310001036044us-gaap:AdditionalPaidInCapitalMember2025-03-310001036044inve:StockOptionsAndRestrictedStockUnitsMemberus-gaap:SellingAndMarketingExpenseMember2024-01-012024-06-300001036044us-gaap:CommonStockMember2024-03-310001036044srt:AsiaPacificMember2024-12-310001036044us-gaap:GeneralAndAdministrativeExpenseMemberinve:StockOptionsAndRestrictedStockUnitsMember2024-04-012024-06-300001036044us-gaap:AdditionalPaidInCapitalMember2023-12-310001036044inve:SeriesBConvertiblePreferredStockMemberus-gaap:PreferredStockMember2025-03-310001036044inve:StockOptionsAndRestrictedStockUnitsMemberus-gaap:SegmentDiscontinuedOperationsMember2024-04-012024-06-300001036044us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMember2025-04-012025-06-300001036044us-gaap:RevenueFromContractWithCustomerMembersrt:AsiaPacificMemberus-gaap:GeographicConcentrationRiskMember2025-01-012025-06-300001036044srt:AmericasMember2025-04-012025-06-300001036044inve:VacatedProductionSpaceMember2025-04-012025-06-300001036044us-gaap:EmployeeSeveranceMember2025-01-012025-06-300001036044us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2024-12-310001036044us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2025-06-300001036044us-gaap:RestrictedStockUnitsRSUMember2025-01-012025-06-300001036044inve:SeriesBConvertiblePreferredStockMember2025-01-012025-06-300001036044us-gaap:GeneralAndAdministrativeExpenseMemberinve:StockOptionsAndRestrictedStockUnitsMember2024-01-012024-06-300001036044srt:AsiaPacificMember2025-06-300001036044inve:StockOptionsAndRestrictedStockUnitsMember2025-01-012025-06-300001036044srt:AmericasMember2025-06-300001036044inve:SeriesBConvertiblePreferredStockMember2024-01-012024-06-300001036044us-gaap:PerformanceSharesMember2024-12-310001036044inve:EuropeAndMiddleEastMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMember2025-01-012025-06-300001036044us-gaap:CommonStockMember2024-01-012024-06-300001036044us-gaap:PerformanceSharesMember2025-06-300001036044us-gaap:CommonStockMember2025-04-012025-06-300001036044us-gaap:AdditionalPaidInCapitalMember2025-04-012025-06-300001036044us-gaap:AdditionalPaidInCapitalMember2025-06-300001036044us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMember2024-04-012024-06-300001036044us-gaap:RetainedEarningsMember2025-04-012025-06-300001036044us-gaap:PerformanceSharesMember2025-04-012025-06-3000010360442024-06-300001036044us-gaap:EmployeeStockOptionMember2025-01-012025-06-300001036044us-gaap:PerformanceSharesMember2025-01-012025-06-300001036044inve:SeriesBConvertiblePreferredStockMember2024-03-310001036044us-gaap:SegmentContinuingOperationsMemberinve:StockOptionsAndRestrictedStockUnitsMember2024-01-012024-06-300001036044us-gaap:AdditionalPaidInCapitalMember2024-12-310001036044us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsNonrecurringMember2025-06-300001036044inve:SeriesBConvertiblePreferredStockMember2024-06-300001036044us-gaap:TreasuryStockCommonMember2024-01-012024-06-300001036044inve:HawkAcquisitionMember2024-01-012024-06-3000010360442024-03-310001036044inve:EuropeAndMiddleEastMember2025-04-012025-06-300001036044inve:SeriesBConvertiblePreferredStockMember2024-12-3100010360442025-06-300001036044inve:HawkAcquisitionMember2024-04-012024-06-3000010360442025-08-040001036044us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-06-300001036044us-gaap:CommonStockMember2024-06-300001036044srt:AmericasMember2024-01-012024-06-300001036044srt:MinimumMember2025-01-012025-06-300001036044us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310001036044us-gaap:RetainedEarningsMember2025-03-310001036044us-gaap:TreasuryStockCommonMember2024-06-300001036044inve:StockOptionsAndRestrictedStockUnitsMemberus-gaap:ResearchAndDevelopmentExpenseMember2025-04-012025-06-3000010360442024-07-012024-09-300001036044us-gaap:SegmentContinuingOperationsMemberinve:StockOptionsAndRestrictedStockUnitsMember2025-04-012025-06-300001036044us-gaap:TreasuryStockCommonMember2024-04-012024-06-300001036044us-gaap:EmployeeStockOptionMember2025-04-012025-06-300001036044us-gaap:TreasuryStockCommonMember2025-03-310001036044us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001036044us-gaap:RestrictedStockUnitsRSUMember2024-01-012024-06-300001036044us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMember2025-01-012025-06-300001036044us-gaap:RetainedEarningsMember2023-12-310001036044srt:AmericasMember2025-01-012025-06-300001036044us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsNonrecurringMember2025-04-012025-06-300001036044inve:PerformanceStockUnitsPsuMember2025-04-012025-06-300001036044inve:BuildingAndLeaseholdImprovementsMember2024-12-310001036044srt:MaximumMember2025-06-300001036044us-gaap:FurnitureAndFixturesMember2025-06-300001036044inve:BuildingAndLeaseholdImprovementsMember2025-06-300001036044inve:SeriesBConvertiblePreferredStockMemberus-gaap:PreferredStockMember2024-12-310001036044inve:StockOptionsAndRestrictedStockUnitsMemberus-gaap:CostOfSalesMember2025-04-012025-06-300001036044inve:StockRepurchaseProgramMember2025-01-012025-06-300001036044us-gaap:CommonStockMember2025-06-300001036044us-gaap:CommonStockMember2024-12-310001036044inve:ImpairmentOfROUOperatingLeaseAssetMember2025-04-012025-06-300001036044inve:ImpairmentOfROUOperatingLeaseAssetMember2025-01-012025-06-300001036044us-gaap:AdditionalPaidInCapitalMember2024-03-310001036044inve:CommonStockIssuableUponConversionOfSeriesBConvertiblePreferredStockMember2025-06-300001036044us-gaap:GeneralAndAdministrativeExpenseMemberinve:StockOptionsAndRestrictedStockUnitsMember2025-04-012025-06-300001036044us-gaap:FairValueMeasurementsRecurringMember2024-12-310001036044us-gaap:AdditionalPaidInCapitalMember2024-01-012024-06-300001036044inve:CommonStockIssuableUponConversionOfSeriesBConvertiblePreferredStockMember2025-01-012025-06-300001036044us-gaap:TreasuryStockCommonMember2025-01-012025-06-300001036044srt:AsiaPacificMember2025-04-012025-06-300001036044us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001036044us-gaap:CommonStockMembersrt:MaximumMember2025-06-300001036044us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMember2024-01-012024-06-300001036044inve:StockOptionsAndRestrictedStockUnitsMemberus-gaap:ResearchAndDevelopmentExpenseMember2025-01-012025-06-300001036044srt:MaximumMember2025-01-012025-06-300001036044us-gaap:TreasuryStockCommonMember2025-06-300001036044us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-04-012024-06-300001036044us-gaap:FairValueMeasurementsNonrecurringMember2024-12-310001036044us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-04-012025-06-300001036044us-gaap:FairValueMeasurementsRecurringMember2025-06-300001036044us-gaap:TreasuryStockCommonMember2025-04-012025-06-300001036044inve:StockOptionsAndRestrictedStockUnitsMember2024-04-012024-06-300001036044us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300001036044inve:EuropeAndMiddleEastMember2024-04-012024-06-300001036044inve:EuropeAndMiddleEastMember2025-06-300001036044inve:StockOptionsAndRestrictedStockUnitsMemberus-gaap:SegmentDiscontinuedOperationsMember2024-01-012024-06-300001036044us-gaap:RestrictedStockUnitsRSUMember2025-04-012025-06-300001036044inve:PerformanceStockUnitsPsuMember2024-01-012024-06-300001036044inve:StockIncentivePlanTwentyElevenMember2025-06-300001036044inve:EuropeAndMiddleEastMember2024-01-012024-06-300001036044inve:CommonStockIssuableUponConversionOfSeriesBConvertiblePreferredStockMember2024-04-012024-06-300001036044us-gaap:PreferredStockMemberinve:SeriesBConvertiblePreferredStockMember2025-06-300001036044inve:SeriesBConvertiblePreferredStockMember2025-06-3000010360442024-01-012024-06-300001036044inve:StockOptionsAndRestrictedStockUnitsMember2024-01-012024-06-300001036044us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2025-06-300001036044us-gaap:SellingAndMarketingExpenseMemberinve:StockOptionsAndRestrictedStockUnitsMember2024-04-012024-06-300001036044us-gaap:RestrictedStockUnitsRSUMember2025-06-300001036044us-gaap:EmployeeStockOptionMember2024-01-012024-06-300001036044inve:SeriesBConvertiblePreferredStockMember2023-12-310001036044inve:EuropeAndMiddleEastMember2025-01-012025-06-300001036044inve:SeriesBConvertiblePreferredStockMember2024-04-012024-06-300001036044srt:AsiaPacificMember2024-04-012024-06-300001036044us-gaap:RetainedEarningsMember2024-01-012024-06-300001036044us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-06-3000010360442025-03-310001036044srt:AmericasMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMember2024-04-012024-06-300001036044srt:AmericasMember2024-04-012024-06-300001036044srt:AmericasMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMember2024-01-012024-06-300001036044us-gaap:RetainedEarningsMember2025-01-012025-06-300001036044us-gaap:USTreasurySecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001036044inve:StockOptionsAndRestrictedStockUnitsMemberus-gaap:ResearchAndDevelopmentExpenseMember2024-01-012024-06-300001036044inve:EuropeAndMiddleEastMember2024-12-310001036044inve:StockOptionsVestingOfRestrictedStockUnitsVestingOfPerformanceStockUnitsAndIssuanceOfRestrictedStockUnitsVestedMember2025-06-300001036044us-gaap:CommonStockMember2023-12-310001036044inve:StockOptionsAndRestrictedStockUnitsMemberus-gaap:CostOfSalesMember2024-04-012024-06-300001036044inve:StockRepurchaseProgramMember2024-11-070001036044inve:PlantAndMachineryMember2025-06-300001036044us-gaap:PreferredStockMemberinve:SeriesBConvertiblePreferredStockMember2023-12-310001036044us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310001036044us-gaap:TreasuryStockCommonMember2023-12-310001036044inve:SeriesBConvertiblePreferredStockMember2025-04-012025-06-300001036044us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001036044inve:PerformanceStockUnitsPsuMember2025-01-012025-06-300001036044us-gaap:RestrictedStockUnitsRSUMember2024-12-310001036044us-gaap:TreasuryStockCommonMember2024-03-310001036044srt:AmericasMember2024-12-310001036044us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-06-30iso4217:USDxbrli:sharesinve:Segmentxbrli:purexbrli:sharesinve:Customeriso4217:USD

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2025

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ______ to ______

 

Commission File Number: 000-29440

 

IDENTIV, INC.

(Exact Name of Registrant as Specified in its Charter)

 

 

Delaware

77-0444317

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

 

 

1900-B Carnegie Avenue

Santa Ana, California

92705

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (657) 356-8384

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of exchange on which registered

 

Common Stock, $0.001 par value per share

 

INVE

 

The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

 

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

As of August 4, 2025, the registrant had 23,721,826 shares of common stock outstanding.

 


 

TABLE OF CONTENTS

Page

PART I. FINANCIAL INFORMATION

 

Item 1.

Financial Statements (Unaudited)

3

 

 

Condensed Consolidated Balance Sheets

3

 

 

Condensed Consolidated Statements of Comprehensive Loss

4

 

 

Condensed Consolidated Statements of Stockholders’ Equity

5

 

 

Condensed Consolidated Statements of Cash Flows

7

 

 

Notes to Unaudited Condensed Consolidated Financial Statements

8

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

19

Item 3.

 

Quantitative and Qualitative Disclosures About Market Risk

26

Item 4.

Controls and Procedures

26

 

 

PART II. OTHER INFORMATION

 

Item 1.

Legal Proceedings

28

Item 1A.

Risk Factors

28

Item 2.

 

Unregistered Sales of Equity Securities and Use of Proceeds

29

Item 5.

 

Other Information

29

Item 6.

 

Exhibits

30

 

 

 

SIGNATURES

31

 

 

 

 

2


 

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

IDENTIV, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited, in thousands, except par value)

 

 

 

June 30,
2025

 

 

December 31,
2024

 

ASSETS

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

129,339

 

 

$

135,646

 

Restricted cash

 

 

300

 

 

 

300

 

Accounts receivable, net of allowances of $660 and $655 as of June 30, 2025
   and December 31, 2024, respectively

 

 

3,466

 

 

 

4,214

 

Inventories

 

 

6,133

 

 

 

7,475

 

Prepaid expenses and other current assets

 

 

4,874

 

 

 

5,210

 

Total current assets

 

 

144,112

 

 

 

152,845

 

Property and equipment, net

 

 

7,526

 

 

 

7,694

 

Operating lease right-of-use assets

 

 

1,395

 

 

 

2,000

 

Other assets

 

 

843

 

 

 

686

 

Total assets

 

$

153,876

 

 

$

163,225

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable

 

$

1,809

 

 

$

2,746

 

Operating lease liabilities

 

 

895

 

 

 

852

 

Accrued compensation and related benefits

 

 

792

 

 

 

862

 

Accrued income taxes payable

 

 

1,223

 

 

 

1,173

 

Other accrued expenses and liabilities

 

 

1,923

 

 

 

2,327

 

Total current liabilities

 

 

6,642

 

 

 

7,960

 

Long-term operating lease liabilities

 

 

790

 

 

 

1,167

 

Other long-term liabilities

 

 

29

 

 

 

29

 

Total liabilities

 

 

7,461

 

 

 

9,156

 

Commitments and contingencies (see Note 14)

 

 

 

 

 

 

Stockholders' equity:

 

 

 

 

 

 

Series B convertible preferred stock, $0.001 par value: 5,000 shares authorized; 5,000 shares
   issued and outstanding as of June 30, 2025 and December 31, 2024

 

 

5

 

 

 

5

 

Common stock, $0.001 par value: 50,000 shares authorized; 26,307 and 25,974 shares
   issued and
23,658 and 23,431 shares outstanding as of June 30, 2025 and
   December 31, 2024, respectively

 

 

26

 

 

 

26

 

Additional paid-in capital

 

 

511,185

 

 

 

509,482

 

Treasury stock, 2,649 and 2,543 shares as of June 30, 2025 and December 31, 2024,
   respectively

 

 

(16,844

)

 

 

(16,490

)

Accumulated deficit

 

 

(350,881

)

 

 

(340,050

)

Accumulated other comprehensive income

 

 

2,924

 

 

 

1,096

 

Total stockholders' equity

 

 

146,415

 

 

 

154,069

 

Total liabilities and stockholders' equity

 

$

153,876

 

 

$

163,225

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

3


 

IDENTIV, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(Unaudited, in thousands, except per share data)

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Net revenue

 

$

5,040

 

 

$

6,741

 

 

$

10,309

 

 

$

13,399

 

Cost of revenue

 

 

5,514

 

 

 

6,127

 

 

 

10,651

 

 

 

12,302

 

Gross profit (loss)

 

 

(474

)

 

 

614

 

 

 

(342

)

 

 

1,097

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

890

 

 

 

966

 

 

 

1,677

 

 

 

1,863

 

Selling and marketing

 

 

1,546

 

 

 

1,828

 

 

 

2,953

 

 

 

2,997

 

General and administrative

 

 

3,057

 

 

 

4,540

 

 

 

6,203

 

 

 

8,020

 

Restructuring and severance

 

 

420

 

 

 

 

 

 

680

 

 

 

 

Total operating expenses

 

 

5,913

 

 

 

7,334

 

 

 

11,513

 

 

 

12,880

 

Loss from continuing operations

 

 

(6,387

)

 

 

(6,720

)

 

 

(11,855

)

 

 

(11,783

)

Non-operating income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

Interest income (expense), net

 

 

1,320

 

 

 

(149

)

 

 

2,532

 

 

 

(236

)

Foreign currency losses, net

 

 

(870

)

 

 

(59

)

 

 

(1,400

)

 

 

(285

)

Loss from continuing operations before income tax benefit (provision)

 

 

(5,937

)

 

 

(6,928

)

 

 

(10,723

)

 

 

(12,304

)

Income tax benefit (provision)

 

 

(105

)

 

 

5

 

 

 

(108

)

 

 

(1

)

Net loss from continuing operations

 

 

(6,042

)

 

 

(6,923

)

 

 

(10,831

)

 

 

(12,305

)

Income from discontinued operations, net of tax

 

 

 

 

 

707

 

 

 

 

 

 

1,531

 

Net loss

 

$

(6,042

)

 

$

(6,216

)

 

 

(10,831

)

 

 

(10,774

)

 

 

 

 

 

 

 

 

 

 

 

 

Other comprehensive income (loss):

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustment, net of tax

 

 

1,236

 

 

 

(104

)

 

 

1,828

 

 

 

(394

)

Comprehensive loss

 

$

(4,806

)

 

$

(6,320

)

 

$

(9,003

)

 

$

(11,168

)

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) per common share:

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted - continuing operations

 

$

(0.26

)

 

$

(0.31

)

 

$

(0.47

)

 

$

(0.55

)

Basic and diluted - discontinued operations

 

$

 

 

$

0.03

 

 

$

 

 

$

0.07

 

Basic and diluted - net loss

 

$

(0.26

)

 

$

(0.27

)

 

$

(0.47

)

 

$

(0.48

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted

 

 

23,760

 

 

 

23,459

 

 

 

23,679

 

 

 

23,413

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

4


 

IDENTIV, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(Unaudited, in thousands)

 

 

 

 

Three Months Ended June 30, 2025

 

 

 

Series B
Convertible Preferred Stock

 

 

Common Stock

 

 

Additional
Paid-in

 

 

Treasury

 

 

Accumulated

 

 

Accumulated
Other
Comprehensive

 

 

Total
Stockholders'

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Stock

 

 

Deficit

 

 

Income

 

 

Equity

 

Balances, April 1, 2025

 

 

5,000

 

 

$

5

 

 

 

23,521

 

 

$

26

 

 

$

510,278

 

 

$

(16,659

)

 

$

(344,839

)

 

$

1,688

 

 

$

150,499

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(6,042

)

 

 

 

 

 

(6,042

)

Unrealized gain from foreign
   currency translation adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,236

 

 

 

1,236

 

Issuance of common stock in connection
   with vesting of stock awards

 

 

 

 

 

 

 

 

195

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

907

 

 

 

 

 

 

 

 

 

 

 

 

907

 

Shares withheld in payment of taxes in
   connection with net share settlement of
   restricted stock units

 

 

 

 

 

 

 

 

(58

)

 

 

 

 

 

 

 

 

(185

)

 

 

 

 

 

 

 

 

(185

)

Balances, June 30, 2025

 

 

5,000

 

 

$

5

 

 

 

23,658

 

 

$

26

 

 

$

511,185

 

 

$

(16,844

)

 

$

(350,881

)

 

$

2,924

 

 

$

146,415

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended June 30, 2025

 

 

 

Series B
Convertible Preferred Stock

 

 

Common Stock

 

 

Additional
Paid-in

 

 

Treasury

 

 

Accumulated

 

 

Accumulated
Other
Comprehensive

 

 

Total
Stockholders'

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Stock

 

 

Deficit

 

 

Income

 

 

Equity

 

Balances, January 1, 2025

 

 

5,000

 

 

$

5

 

 

 

23,431

 

 

$

26

 

 

$

509,482

 

 

$

(16,490

)

 

$

(340,050

)

 

$

1,096

 

 

$

154,069

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(10,831

)

 

 

 

 

 

(10,831

)

Unrealized loss from foreign
   currency translation adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,828

 

 

 

1,828

 

Issuance of common stock in connection
   with vesting of stock awards

 

 

 

 

 

 

 

 

333

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,703

 

 

 

 

 

 

 

 

 

 

 

 

1,703

 

Shares withheld in payment of taxes in
   connection with net share settlement of
   restricted stock units

 

 

 

 

 

 

 

 

(106

)

 

 

 

 

 

 

 

 

(354

)

 

 

 

 

 

 

 

 

(354

)

Balances, June 30, 2025

 

 

5,000

 

 

$

5

 

 

 

23,658

 

 

$

26

 

 

$

511,185

 

 

$

(16,844

)

 

$

(350,881

)

 

$

2,924

 

 

$

146,415

 

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

 

 

5


 

 

 

Three Months Ended June 30, 2024

 

 

 

Series B
Convertible Preferred Stock

 

 

Common Stock

 

 

Additional
Paid-in

 

 

Treasury

 

 

Accumulated

 

 

Accumulated
Other
Comprehensive

 

 

Total
Stockholders'

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Stock

 

 

Deficit

 

 

Income

 

 

Equity

 

Balances, April 1, 2024

 

 

5,000

 

 

$

5

 

 

 

23,334

 

 

$

25

 

 

$

501,771

 

 

$

(13,246

)

 

$

(419,428

)

 

$

1,039

 

 

$

70,166

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(6,216

)

 

 

 

 

 

(6,216

)

Unrealized loss from foreign
   currency translation adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(104

)

 

 

(104

)

Issuance of common stock in connection
   with vesting of stock awards

 

 

 

 

 

 

 

 

168

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,475

 

 

 

 

 

 

 

 

 

 

 

 

1,475

 

Shares withheld in payment of taxes in
   connection with net share settlement of
   restricted stock units

 

 

 

 

 

 

 

 

(54

)

 

 

 

 

 

 

 

 

(264

)

 

 

 

 

 

 

 

 

(264

)

Balances, June 30, 2024

 

 

5,000

 

 

$

5

 

 

 

23,448

 

 

$

25

 

 

$

503,246

 

 

$

(13,510

)

 

$

(425,644

)

 

$

935

 

 

$

65,057

 

 

 

 

Six Months Ended June 30, 2024

 

 

 

Series B
Convertible Preferred Stock

 

 

Common Stock

 

 

Additional
Paid-in

 

 

Treasury

 

 

Accumulated

 

 

Accumulated
Other
Comprehensive

 

 

Total
Stockholders'

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Stock

 

 

Deficit

 

 

Income

 

 

Equity

 

Balances, January 1, 2024

 

 

5,000

 

 

$

5

 

 

 

23,247

 

 

$

25

 

 

$

500,752

 

 

$

(12,969

)

 

$

(414,870

)

 

$

1,329

 

 

$

74,272

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(10,774

)

 

 

 

 

 

(10,774

)

Unrealized loss from foreign
   currency translation adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(394

)

 

 

(394

)

Issuance of common stock in connection
   with vesting of stock awards

 

 

 

 

 

 

 

 

288

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,494

 

 

 

 

 

 

 

 

 

 

 

 

2,494

 

Shares withheld in payment of taxes in
   connection with net share settlement of
   restricted stock units

 

 

 

 

 

 

 

 

(87

)

 

 

 

 

 

 

 

 

(541

)

 

 

 

 

 

 

 

 

(541

)

Balances, June 30, 2024

 

 

5,000

 

 

$

5

 

 

 

23,448

 

 

$

25

 

 

$

503,246

 

 

$

(13,510

)

 

$

(425,644

)

 

$

935

 

 

$

65,057

 

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

 

6


 

IDENTIV, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited, in thousands)

 

 

 

Six Months Ended June 30,

 

 

 

2025

 

 

2024

 

Cash flows from operating activities:

 

 

 

 

 

 

Net loss

 

$

(10,831

)

 

$

(10,774

)

Adjustments to reconcile net loss to net cash used in
   operating activities:

 

 

 

 

 

 

Depreciation and amortization

 

 

980

 

 

 

1,524

 

Amortization of operating lease right-of-use assets

 

 

307

 

 

 

525

 

Amortization of debt issuance costs

 

 

 

 

 

69

 

Stock-based compensation expense

 

 

1,703

 

 

 

2,494

 

Impairment of operating lease right-of-use asset

 

 

346

 

 

 

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

Accounts receivable

 

 

783

 

 

 

2,377

 

Inventories

 

 

1,369

 

 

 

1,630

 

Prepaid expenses and other assets

 

 

208

 

 

 

573

 

Accounts payable

 

 

(933

)

 

 

(2,266

)

Deferred revenue

 

 

 

 

 

344

 

Accrued income taxes payable

 

 

51

 

 

 

38

 

Accrued expenses and other liabilities

 

 

(448

)

 

 

1,710

 

Operating lease liabilities

 

 

(383

)

 

 

(538

)

Net cash used in operating activities

 

 

(6,848

)

 

 

(2,294

)

Cash flows from investing activities:

 

 

 

 

 

 

Capital expenditures

 

 

(553

)

 

 

(367

)

Net cash used in investing activities

 

 

(553

)

 

 

(367

)

Cash flows from financing activities:

 

 

 

 

 

 

Borrowings under revolving loan facility, net of issuance costs

 

 

 

 

 

9,887

 

Repayments under revolving loan facility

 

 

 

 

 

(12,000

)

Taxes paid related to net share settlement of restricted stock units

 

 

(354

)

 

 

(541

)

Net cash used in financing activities

 

 

(354

)

 

 

(2,654

)

Effect of exchange rates on cash, cash equivalents, and restricted cash

 

 

1,448

 

 

 

(68

)

Net decrease in cash, cash equivalents, and restricted cash

 

 

(6,307

)

 

 

(5,383

)

Cash, cash equivalents, and restricted cash at beginning of period

 

 

135,946

 

 

 

24,384

 

Cash, cash equivalents, and restricted cash at end of period

 

$

129,639

 

 

$

19,001

 

 

 

 

 

 

 

 

Supplemental disclosures of cash flow information:

 

 

 

 

 

 

Interest paid

 

$

 

 

$

201

 

Taxes paid

 

$

158

 

 

$

57

 

Non-cash investing and financing activities:

 

 

 

 

 

 

Operating lease right-of-use assets obtained in exchange for operating lease liabilities

 

$

40

 

 

$

368

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

7


 

IDENTIV, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2025

 

Note 1. Basis of Presentation

The accompanying unaudited condensed consolidated financial statements include the accounts of Identiv, Inc. and its wholly owned subsidiaries (the “Company”). All intercompany balances and transactions have been eliminated in consolidation. Certain reclassifications have been made to the fiscal 2024 condensed consolidated financial statements to conform with the fiscal 2025 presentation. The reclassifications had no impact on net loss, total assets, total liabilities, or stockholders' equity.

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation of the Company’s unaudited condensed consolidated financial statements have been included. The results of operations for the three and six months ended June 30, 2025 are not necessarily indicative of the results that may be expected for the year ending December 31, 2025 or any future period. The unaudited condensed consolidated balance sheet as of December 31, 2024 has been derived from audited consolidated financial statements at that date, but does not include all disclosures required by U.S. GAAP for complete financial statements. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” “Risk Factors,” and the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, as well as “Risk Factors” in the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025.

On September 6, 2024, the Company completed the sale of its physical security, access card, and identity reader operations and assets, including all outstanding shares of Identiv Private Limited, its wholly-owned subsidiary (the “Physical Security Business"), to Hawk Acquisition, Inc., a Delaware corporation (“Buyer”) and a wholly-owned subsidiary of Vitaprotech SAS, a French société par actions simplifiée and provider of security solutions. Due to the sale of its Physical Security Business in 2024, the Company has classified the results of the Physical Security Business as discontinued operations on its condensed consolidated statements of comprehensive loss for the 2024 periods presented. See Note 3, Discontinued Operations for additional disclosure related to discontinued operations. The discussion in the notes to these condensed consolidated financial statements, unless otherwise noted, relates solely to the Company's continuing operations.

Note 2. Significant Accounting Policies and Recent Accounting Pronouncements

Significant Accounting Policies

No material changes have been made to the Company's significant accounting policies disclosed in Note 2, Summary of Significant Accounting Policies, in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.

Recent Accounting Pronouncements

From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board ("FASB") or other standard setting bodies that the Company adopts as of the specified effective date. Unless otherwise discussed, the Company does not believe that the impact of recently issued standards that are not yet effective will have a material impact on its financial position or results of operations upon adoption.

In December 2023, the FASB released Accounting Standards Update ("ASU") 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which amends income tax disclosure requirements to enhance the transparency and decision usefulness for users of the consolidated financial statements. The standard will be effective for the Company beginning with its annual financial statements for the fiscal year ending December 31, 2025. The Company is currently evaluating the impact of this standard, if any, on its financial statement disclosures.

In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income (Topic 220): Disaggregation of Income Statement Expenses (“ASU 2024-03”), which requires public entities to provide disaggregated disclosures of certain expense captions presented on the face of the income statement into specific categories within the notes to the consolidated financial statements. ASU 2024-03 is effective for the Company’s annual periods beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The ASU may be applied either on a prospective or retrospective basis. The Company is currently evaluating the impact of adoption of ASU 2024-03 on its financial statements and related disclosures.

8


 

In July 2024, the FASB issued ASU 2025-05, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets, which amends ASC 326-20 to provide a practical expedient (for all entities) and an accounting policy election (for all entities, other than public business entities, that elect the practical expedient) related to the estimation of expected credit losses for current accounts receivable and current contract assets that arise from transactions accounted for under ASC 606. The standard is effective for annual reporting periods beginning after December 15, 2025, including interim periods, and allows for early adoption. The Company is currently evaluating the impact on its financial statements and related disclosures.

Note 3. Discontinued Operations

On September 6, 2024, the Company completed the sale of its Physical Security Business to Buyer, and Buyer assumed certain of the Company’s liabilities related to the Physical Security Business (collectively, the “Asset Sale”) pursuant to that certain Stock and Asset Purchase Agreement, dated as of April 2, 2024, by and between the Company and Buyer. As consideration for the Asset Sale, the Company received approximately $143.9 million in cash.

In connection with the closing of the Asset Sale, the Company and Buyer entered into a transition services agreement (the “Transition Services Agreement”). The Transition Services Agreement outlines the information technology, people, and facility support the Company will provide to Buyer for a period of 12 months to 18 months after the transaction closing date. The agreed upon charges for such services are intended to allow the Company and Buyer, respectively, to recover all costs and expenses of providing such services. Fees earned and incurred under the Transition Services Agreement for the three and six months ended June 30, 2025 were immaterial.

As the sale of the Company's Physical Security Business represented a significant strategic shift that has a material effect on the Company's operations and financial results, the Company has separately reported the results of its Physical Security Business as discontinued operations in the condensed consolidated statement of comprehensive loss for the 2024 periods presented.

The following presents the financial results of discontinued operations (in thousands):

 

Three Months Ended
June 30, 2024

 

 

Six Months Ended
June 30, 2024

 

Net revenue

$

17,592

 

 

$

33,428

 

Cost of revenue

 

9,688

 

 

 

17,615

 

Gross profit

 

7,904

 

 

 

15,813

 

Operating expenses:

 

 

 

 

 

Research and development

 

2,089

 

 

 

4,203

 

Selling and marketing

 

4,207

 

 

 

8,340

 

General and administrative

 

729

 

 

 

1,501

 

Restructuring and severance

 

123

 

 

 

145

 

Total operating expenses

 

7,148

 

 

 

14,189

 

Income from operations

 

756

 

 

 

1,624

 

Non-operating income (expense):

 

 

 

 

 

Foreign currency losses, net

 

(15

)

 

 

(45

)

Income before income tax provision

 

741

 

 

 

1,579

 

Income tax provision

 

(34

)

 

 

(48

)

Income from discontinued operations

$

707

 

 

$

1,531

 

 

The cash flows related to the discontinued operations have not been segregated and are included in the condensed consolidated statements of cash flows. The following presents the significant non-cash items and capital expenditures related to discontinued operations (in thousands):

 

Three Months Ended June 30, 2024

 

 

Six Months
Ended June 30, 2024

 

Depreciation and amortization

$

333

 

 

$

666

 

Capital expenditures

 

59

 

 

 

130

 

Stock-based compensation

 

490

 

 

 

990

 

 

9


 

Note 4. Revenue

Revenue Recognition

Revenue is recognized upon transfer of control of promised products to customers in an amount that reflects the consideration the Company expects to receive in exchange for those products. For contracts with multiple performance obligations, the Company allocates the transaction price of the contract to each performance obligation, generally on a relative basis using its standalone selling price. The stated contract value is generally the transaction price to be allocated to the separate performance obligations. Revenue is recognized net of any taxes collected from customers that are subsequently remitted to governmental authorities.

Disaggregation of Revenue

The Company disaggregates revenue from contracts with customers based on the shipping location of the customer. The geographic regions that are tracked are the Americas, Europe and the Middle East, and Asia-Pacific regions. See Note 11, Segment Reporting, for net revenue based on the disaggregation criteria noted above. All revenues from continuing operations are recognized at a point-in-time following the transfer of control of the products to the customer, which typically occurs upon shipment or delivery depending on the terms of the underlying contract.

Note 5. Fair Value Measurements

The Company determines the fair values of its financial instruments based on a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The classification of a financial asset or liability within the hierarchy is based upon the lowest level input that is significant to the fair value measurement. Under Accounting Standards Codification ("ASC") ASC 820, Fair Value Measurement and Disclosures, the fair value hierarchy prioritizes the inputs into three levels that may be used to measure fair value:

Level 1 – Quoted prices (unadjusted) for identical assets and liabilities in active markets;
Level 2 – Inputs other than quoted prices in active markets for identical assets and liabilities that are observable either directly or indirectly; and
Level 3 – Unobservable inputs.

Assets and Liabilities Measured at Fair Value on a Recurring Basis

As of June 30, 2025 and December 31, 2024, the only assets measured and recognized at fair value on a recurring basis were cash equivalents, which consisted of amounts held in money market accounts of $16.3 million and $31.6 million, respectively, and treasury bills of $110.7 million and $83.0 million, respectively, with maturities less than 90 days (Level 1 fair value measurements). As of June 30, 2025 and December 31, 2024, there were no liabilities measured and recognized at fair value on a recurring basis.

Assets and Liabilities Measured at Fair Value on a Non-recurring Basis

Certain of the Company's assets are measured at fair value on a nonrecurring basis if impairment is indicated. As of June 30, 2025 and December 31, 2024, the Company had $498,000, which included the conversion of a convertible promissory note of $150,000 in the second quarter of 2025, and $348,000, respectively, of privately-held investments measured at fair value on a nonrecurring basis. These assets were classified as Level 3 due to the absence of quoted market prices and inherent lack of liquidity. The Company reviews its investments to identify and evaluate investments that have an indication of possible impairment. The Company adjusts the carrying value for its privately-held investments for any impairment if the fair value is less than the carrying value of the respective assets on an other-than-temporary basis. The amount of privately-held investments is included in other assets in the accompanying condensed consolidated balance sheets.

As of June 30, 2025 and December 31, 2024, there were no liabilities that are measured and recognized at fair value on a non-recurring basis.

Assets and Liabilities Not Measured at Fair Value

The carrying amounts of the Company's accounts receivable, prepaid expenses and other current assets, accounts payable, and other accrued liabilities approximate fair value due to their short maturities.

10


 

 

Note 6. Balance Sheet Components

 

The Company’s inventories are stated at the lower of cost or net realizable value. Inventories consist of (in thousands):

 

 

June 30,
2025

 

 

December 31,
2024

 

Raw materials

 

$

3,162

 

 

$

3,893

 

Work-in-progress

 

 

55

 

 

 

 

Finished goods

 

 

2,916

 

 

 

3,582

 

Total

 

$

6,133

 

 

$

7,475

 

 

Property and equipment, net consists of (in thousands):

 

June 30,
2025

 

 

December 31,
2024

 

Building and leasehold improvements

 

$

1,644

 

 

$

1,315

 

Furniture, fixtures and office equipment

 

 

266

 

 

 

221

 

Plant and machinery

 

 

16,786

 

 

 

17,967

 

Purchased software

 

 

769

 

 

 

724

 

Total

 

 

19,465

 

 

 

20,227

 

Accumulated depreciation

 

 

(11,939

)

 

 

(12,533

)

Property and equipment, net

 

$

7,526

 

 

$

7,694

 

 

The Company recorded depreciation expense of $490,000 and $429,000 during the three months ended June 30, 2025 and 2024, respectively, and $980,000 and $858,000 during the six months ended June 30, 2025 and 2024, respectively. Depreciation expense included in discontinued operations was $93,000 and $186,000 for the three and six months ended June 30, 2024, respectively.

Other accrued expenses and liabilities consist of (in thousands):

 

 

 

 

June 30,
2025

 

 

December 31,
2024

 

Accrued professional fees

 

$

516

 

 

$

526

 

Accrued warranties

 

 

324

 

 

 

214

 

Amounts payable under the Transition Services Agreement

 

 

297

 

 

 

354

 

Amounts payable related to purchase price adjustment

 

 

 

 

 

474

 

Other accrued expenses

 

 

786

 

 

 

759

 

Total

 

$

1,923

 

 

$

2,327

 

 

Note 7. Income Taxes

The Company conducts business globally and, as a result, files federal, state and foreign tax returns. The Company strives to resolve open matters with each tax authority at the examination level and could reach agreements with a tax authority at any time. While the Company has accrued for amounts it believes are the probable outcomes, the final outcome with a tax authority may result in a tax liability that is more or less than that reflected in the condensed consolidated financial statements. Furthermore, the Company may later decide to challenge any assessments, if made, and may exercise its right to appeal.

The Company applies the provisions of, and accounted for uncertain tax positions, in accordance with ASC 740, Income Taxes (“ASC 740”), which clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements. It prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC 740 also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition.

The Company generally is no longer subject to tax examinations for years prior to 2020. However, if loss carryforwards of tax years prior to 2017 are utilized in the U.S., these tax years may become subject to investigation by the tax authorities. While timing of the resolution and/or finalization of tax audits is uncertain, the Company does not believe that its unrecognized tax benefits would materially change in the next 12 months.

On July 4, 2025, President Trump signed H.R. 1, the “One Big Beautiful Bill Act,” into law. In accordance with GAAP, the

11


 

Company will account for the tax effects of changes in tax law in the period of enactment, which is the third quarter of calendar year 2025. The Company is currently in the process of analyzing the tax impacts of the law change, if any, but does not expect a material impact on its financial statements.

Note 8. Stockholders’ Equity

Series B Convertible Preferred Stock and Dividend Accretion

The following table summarizes Series B convertible preferred stock and the accretion of dividend activity for the three and six months ended June 30, 2025 and 2024 (in thousands):

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Series B Convertible Preferred Stock:

 

 

 

 

 

 

Balance at beginning of period

 

$

27,677

 

$

26,837

 

 

$

27,472

 

$

26,589

 

Cumulative dividends on Series B convertible preferred stock

 

 

205

 

 

233

 

 

 

410

 

 

481

 

Balance at end of period

 

$

27,882

 

$

27,070

 

 

$

27,882

 

$

27,070

 

Number of Common Shares Issuable Upon Conversion:

 

 

 

 

 

 

Number of shares at beginning of period

 

 

6,919

 

 

6,709

 

 

 

6,868

 

 

6,647

 

Cumulative dividends on Series B convertible preferred stock

 

 

52

 

 

58

 

 

 

103

 

 

120

 

Number of shares at end of period

 

 

6,971

 

 

6,767

 

 

 

6,971

 

 

6,767

 

 

Based on the current conversion price, the outstanding shares, including the accretion of dividends, of Series B convertible preferred stock as of June 30, 2025 would be convertible into 6,970,507 shares of the Company’s common stock. However, the conversion rate will be subject to adjustment in certain instances, such as if the Company issues shares of its common stock at a price less than $4.00 per common share, subject to a minimum conversion price of $3.27 per share. As of June 30, 2025, none of the contingent conditions to adjust the conversion rate had been met.

Each share of Series B convertible preferred stock is entitled to a cumulative annual dividend of 5% for the first six years following the issuance of such share and 3% for each year thereafter, with the Company retaining the option to settle each year’s dividend after the 10th year in cash. The dividends accrue and are payable in kind upon such time as the shares convert into the Company’s common stock. In general, the shares are not entitled to vote except in certain limited cases, including in change of control transactions where the expected price per share distributable to the Company’s stockholders is expected to be less than $4.00 per share. The Certificate of Designation with respect to the Series B convertible preferred stock further provides that in the event of, among other things, any change of control, liquidation or dissolution of the Company, the holders of the Series B convertible preferred stock will be entitled to receive, on a pari passu basis with the holders of the common stock, the same amount and form of consideration that the holders of the Company’s common stock receive (on an as-if-converted-to-common-stock basis and without regard to the Beneficial Ownership Limitation (as defined in the Certificate of Designation) applicable to the Series B convertible preferred stock).

Stock Repurchases

On November 7, 2024, the Company announced that its board of directors authorized a stock repurchase program (the “Stock Repurchase Program”), pursuant to which the Company may purchase up to $10,000,000 of its common stock. Under the Stock Repurchase Program, effective November 15, 2024, the Company may repurchase shares of common stock on a discretionary basis from time to time through open market repurchases, privately negotiated transactions, or other means. The timing and amount of shares repurchased depends on a number of factors, including stock price, trading volume, general market and business conditions, liquidity and capital needs, and other factors. The Stock Repurchase Program does not obligate the Company to repurchase any specific dollar amount or acquire any specific number of shares of common stock. The Stock Repurchase Program has no expiration date and may be suspended or discontinued at any time without notice.

As of June 30, 2025, the Company repurchased a total of 463,779 shares of common stock under the Stock Repurchase Program for total consideration of approximately $1.9 million. During the six months ended June 30, 2025, there were no repurchases of shares of common stock under the Stock Repurchase Program.

During the six months ended June 30, 2025, the Company repurchased 105,862 shares of our common stock surrendered to the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") issued to employees.

12


 

Common Stock Reserved for Future Issuance

Common stock reserved for future issuance as of June 30, 2025 was as follows:

 

 

 

Number of Shares

 

Exercise of outstanding stock options, vesting of restricted stock units ("RSUs"), vesting of performance stock units ("PSUs") and issuance of RSUs vested but not released

 

 

1,587,885

 

Employee Stock Purchase Plan

 

 

293,888

 

Shares of common stock available for grant under the 2011 Plan

 

 

714,857

 

Shares of common stock issuable upon conversion of Series B convertible preferred stock

 

 

7,541,449

 

Total

 

 

10,138,079

 

 

Note 9. Stock-Based Compensation

Stock Options

A summary of stock option activity for the six months ended June 30, 2025 is as follows:

 

 

 

Number
Outstanding

 

 

Weighted Average Exercise
Price per Share

 

 

Weighted Average
Remaining
Contractual Term
(Years)

 

 

Aggregate
Intrinsic
Value

 

Balance as of January 1, 2025

 

 

444,460

 

 

$

4.36

 

 

 

1.43

 

 

$

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

Cancelled or Expired

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of June 30, 2025

 

 

444,460

 

 

$

4.36

 

 

 

0.93

 

 

$

 

Vested or expected to vest as of June 30, 2025

 

 

444,460

 

 

$

4.36

 

 

 

0.93

 

 

$

 

Exercisable as of June 30, 2025

 

 

444,460

 

 

$

4.36

 

 

 

0.93

 

 

$

 

 

The aggregate intrinsic value in the table above represents the difference between the fair value of the Company’s common stock as of June 30, 2025 and the exercise price of in-the-money stock options multiplied by the number of such stock options. As of June 30, 2025, there was no unrecognized stock-based compensation expense related to stock options.

Restricted Stock Units

The following is a summary of RSU activity for the six months ended June 30, 2025:

 

 

 

Number
Outstanding

 

 

Weighted Average
Fair Value

 

Unvested as of January 1, 2025

 

 

806,985

 

 

$

6.31

 

Granted

 

 

196,500

 

 

 

3.47

 

Vested

 

 

(253,853

)

 

 

6.26

 

Forfeited

 

 

(72,911

)

 

 

6.75

 

Unvested as of June 30, 2025

 

 

676,721

 

 

$

5.46

 

RSUs vested but not released

 

 

134,204

 

 

$

5.41

 

 

The fair value of the Company’s RSUs is calculated based upon the fair market value of the Company’s common stock at the date of grant. As of June 30, 2025, there was $3.0 million of unrecognized compensation expense related to unvested RSUs granted, which is expected to be recognized over a weighted average period of 2.06 years. No tax benefit was realized from RSUs for the six months ended June 30, 2025.

13


 

Performance Stock Units

The Company grants to certain key employees PSUs that are subject to the attainment of performance goals established by the Company’s Compensation Committee, the periods during which performance is to be measured, and other limitations and conditions. Performance goals are based on pre-established objectives that specify the manner of determining the number of PSUs that will vest if performance goals are attained. If an employee terminates employment, the non-vested portion of the PSUs will not vest and all rights to the non-vested portion terminate.

 

The following is a summary of PSU activity for the six months ended June 30, 2025:

 

 

Number
Outstanding

 

 

Weighted Average
Fair Value

 

Unvested as of January 1, 2025

 

 

417,500

 

 

$

4.07

 

Granted

 

 

20,000

 

 

 

3.51

 

Vested

 

 

(105,000

)

 

 

4.07

 

Forfeited

 

 

 

 

 

 

Unvested as of June 30, 2025

 

 

332,500

 

 

$

4.04

 

 

As of June 30, 2025, there was $890,000 of unrecognized compensation expense related to unvested PSUs, which is expected to be recognized over a period of 0.5 years. No tax benefit was realized from PSUs for the three and six months ended June 30, 2025.

Stock-Based Compensation Expense

The following table summarizes stock-based compensation expense related to stock options, RSUs and PSUs included in the condensed consolidated statements of comprehensive loss for the three and six months ended June 30, 2025 and 2024 (in thousands):

 

 

 

Three Months Ended June 30,

Six Months Ended June 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Cost of revenue

 

$

5

 

 

$

5

 

 

$

10

 

 

$

12

 

Research and development

 

 

32

 

 

 

43

 

 

 

52

 

 

 

77

 

Selling and marketing

 

 

77

 

 

 

443

 

 

 

136

 

 

 

561

 

General and administrative

 

 

793

 

 

 

494

 

 

 

1,505

 

 

 

854

 

Stock-based compensation expense - continuing operations

 

 

907

 

 

 

985

 

 

 

1,703

 

 

 

1,504

 

Stock-based compensation expense - discontinued operations

 

 

 

 

 

490

 

 

 

 

 

 

990

 

Total

 

$

907

 

 

$

1,475

 

 

$

1,703

 

 

$

2,494

 

 

Restricted Stock Unit Net Share Settlements

During the six months ended June 30, 2025 and 2024, the Company repurchased 105,862 and 86,340 shares, respectively, of common stock surrendered to the Company to satisfy tax withholding obligations in connection with the vesting of RSUs issued to employees.

14


 

Note 10. Net Loss per Common Share

Basic net loss per common share is computed by dividing net loss available to common stockholders during the period by the weighted average number of common shares outstanding during that period. Diluted net loss per common share is impacted by equity instruments considered to be potential common shares, if dilutive, computed using the treasury stock or the if-converted method of accounting. Dilutive potential common share equivalents are excluded from the computation of net loss per share in loss periods, as their effect would be anti-dilutive.

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Net loss from continuing operations

 

$

(6,042

)

 

$

(6,923

)

 

$

(10,831

)

 

$

(12,305

)

Net income from discontinued operations, net of tax

 

 

 

 

 

707

 

 

 

 

 

 

1,531

 

Net loss

 

 

(6,042

)

 

 

(6,216

)

 

 

(10,831

)

 

 

(10,774

)

Less: accretion of Series B convertible preferred stock dividends

 

 

(205

)

 

 

(233

)

 

 

(410

)

 

 

(481

)

Net loss available to common stockholders

 

$

(6,247

)

 

$

(6,449

)

 

$

(11,241

)

 

$

(11,255

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding - basic

 

 

23,760

 

 

23,459

 

 

 

23,679

 

 

23,413

 

Effect of dilutive potential common shares

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding - diluted

 

 

23,760

 

 

 

23,459

 

 

 

23,679

 

 

 

23,413

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted net income (loss) per common share:

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

(0.26

)

 

$

(0.31

)

 

$

(0.47

)

 

$

(0.55

)

Discontinued operations, net of tax

 

$

 

 

$

0.03

 

 

$

 

 

$

0.07

 

Net loss per common share

 

$

(0.26

)

 

$

(0.27

)

 

$

(0.47

)

 

$

(0.48

)

The following common stock equivalents have been excluded from diluted net loss per share for the three and six months ended June 30, 2025 and 2024 because their inclusion would have been anti-dilutive (in thousands):

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Shares of common stock subject to outstanding RSUs

 

 

677

 

 

 

1,100

 

 

 

677

 

 

 

1,100

 

Shares of common stock subject to outstanding PSUs

 

 

333

 

 

 

 

 

 

333

 

 

 

 

Shares of common stock subject to outstanding stock options

 

 

444

 

 

 

485

 

 

 

444

 

 

 

485

 

Shares of common stock issuable upon conversion of Series B
   convertible preferred stock

 

 

6,971

 

 

 

6,767

 

 

 

6,971

 

 

 

6,767

 

Total

 

 

8,425

 

 

 

8,352

 

 

 

8,425

 

 

 

8,352

 

 

Note 11. Segment Reporting

Segment Reporting

Historically, the Company organized its operations into two reportable business segments: Identity and Premises. The Identity segment included products and solutions that enabled secure access to information serving the logical access and cyber-security market, and protected connected objects and information using radio-frequency identification ("RFID") embedded security. The Premises segment included the Company's solutions to address the premises security market for government and enterprise, including access control, video surveillance, analytics, audio, access readers and identities.

As disclosed in Note 1, Basis of Presentation and Note 3, Discontinued Operations, in the third quarter of 2024, the Company completed the sale of its Physical Security Business, which historically represented the Company's Premises segment, as well as its access card and identity reader operations, which were historically part of its Identity segment. As a result, the Company has one reportable segment: the Internet of Things ("IoT") Business segment.

15


 

The chief operating decision maker ("CODM") assesses performance for the segment and decides how to allocate resources based on consolidated loss from continuing operations that also is reported on the condensed consolidated statements of comprehensive loss. The measure of segment assets is reported on the condensed consolidated balance sheets as total consolidated assets. Loss from continuing operations is used to monitor budget versus actual results. Monitoring of budgeted versus actual results are used in assessing performance of the segment and in establishing management’s compensation. The Company derives revenue primarily in the Americas, Europe and the Middle East, and Asia-Pacific regions and manages the business activities on a consolidated basis. The Company’s CODM is the chief executive officer.

Significant Segment Expenses

As the Company's CODM manages operations on a consolidated basis, consolidated net loss from continuing operations as reported in the Company's condensed consolidated statements of comprehensive loss is the U.S. GAAP measure that is used to make operating decisions and evaluate operating performance. The significant expense categories which are used to manage operations are those reflected in the Company's condensed consolidated statements of comprehensive loss.

Geographic Information

Geographic net revenue is based on the customer’s ship-to location. Information regarding net revenue by geographic region for the three and six months ended June 30, 2025 and 2024 is as follows (in thousands):

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Americas

 

$

1,833

 

 

$

3,386

 

 

$

4,071

 

 

$

6,344

 

Europe and the Middle East

 

 

1,964

 

 

 

2,068

 

 

 

3,751

 

 

 

4,606

 

Asia-Pacific

 

 

1,243

 

 

 

1,287

 

 

 

2,487

 

 

 

2,449

 

Total

 

$

5,040

 

 

$

6,741

 

 

$

10,309

 

 

$

13,399

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As percentage of net revenue:

 

 

 

 

 

 

 

 

 

 

 

 

Americas

 

 

36

%

 

 

50

%

 

 

39

%

 

 

47

%

Europe and the Middle East

 

 

39

%

 

 

31

%

 

 

36

%

 

 

34

%

Asia-Pacific

 

 

25

%

 

 

19

%

 

 

25

%

 

 

19

%

Total

 

 

100

%

 

 

100

%

 

 

100

%

 

 

100

%

Concentration of Credit Risk

One customer accounted for 19% of net revenue for the three months ended June 30, 2025. One customer accounted for 18% of net revenue for the six months ended June 30, 2025. Two customers accounted for 18% and 11%, respectively, of net revenue for the three months ended June 30, 2024. Two customers accounted for 12% and 10%, respectively, of net revenue for the six months ended June 30, 2024. Two customers accounted for 15% and 10%, respectively, of net accounts receivable as of June 30, 2025. Two customers accounted for 16% and 11%, respectively, of net accounts receivable as of December 31, 2024.

Long-lived assets by geographic location as of June 30, 2025 and December 31, 2024 are as follows (in thousands):

 

 

 

June 30,
2025

 

 

December 31,
2024

 

Property and equipment, net:

 

 

 

 

 

 

Americas

 

$

117

 

 

$

68

 

Europe and the Middle East

 

 

628

 

 

 

475

 

Asia-Pacific

 

 

6,781

 

 

 

7,151

 

Total property and equipment, net

 

$

7,526

 

 

$

7,694

 

 

 

 

 

 

 

 

Operating lease right-of-use assets:

 

 

 

 

 

 

Americas

 

$

 

 

$

 

Europe and the Middle East

 

 

334

 

 

 

335

 

Asia-Pacific

 

 

1,061

 

 

 

1,665

 

Total operating lease right-of-use assets

 

$

1,395

 

 

$

2,000

 

 

 

16


 

Note 12. Restructuring and Severance

During the three and six months ended June 30, 2025, restructuring expenses consist of severance costs of $312,000 and $334,000, respectively, and impairments of an operating lease right-of-use asset of $108,000 and $346,000, respectively, primarily associated with shutdown related activities and vacated production space at the Company's Singapore manufacturing facility.

Note 13. Leases

The Company’s leases consist primarily of operating leases for administrative office space, research and development facilities, manufacturing facilities, and sales offices in various countries around the world. The Company determines if an arrangement is a lease at inception. Some lease agreements contain lease and non-lease components, which are accounted for as a single lease component. Total rent expense was $0.2 million and $0.4 million for the three and six months ended June 30, 2025, respectively, and $0.2 million and $0.4 million for the three and six months ended June 30, 2024, respectively.

Initial lease terms are determined at commencement and may include options to extend or terminate the lease when it is reasonably certain the Company will exercise the option. Remaining lease terms range from one to three years, some of which include options to extend for up to five years. Leases with an initial term of 12 months or less are not recorded on the condensed consolidated balance sheets. As the Company’s leases do not provide an implicit rate, the present value of future lease payments is determined using the Company’s incremental borrowing rate based on information available at the lease commencement date.

The table below reconciles the undiscounted cash flows for the remaining years to the operating lease liabilities recorded on the condensed consolidated balance sheet as of June 30, 2025 (in thousands):

 

 

June 30,
2025

 

2025 (remaining six months)

 

$

522

 

2026

 

 

839

 

2027

 

 

402

 

2028

 

 

58

 

Total minimum lease payments

 

 

1,821

 

Less: amount of lease payments representing interest

 

 

(136

)

Present value of future minimum lease payments

 

 

1,685

 

Less: current liabilities under operating leases

 

 

(895

)

Long-term operating lease liabilities

 

$

790

 

 

As of June 30, 2025, the weighted average remaining lease term for the Company’s operating leases was 2.2 years, and the weighted average discount rate used to determine the present value of the Company’s operating leases was 7.7%.

In the three and six months ended June 30, 2025, the Company recorded impairment charges of $108,000 and $346,000, respectively, related to an operating lease right-of-use asset associated with vacated production space at its Singapore manufacturing facility.

Cash paid for amounts included in the measurement of operating lease liabilities was $257,000 and $521,000 for the three and six months ended June 30, 2025, respectively, and $248,000 and $478,000 for the three and six months ended June 30, 2024, respectively.

 

17


 

Note 14. Commitments and Contingencies

The following table summarizes the Company’s principal contractual commitments, excluding operating leases, as of June 30, 2025 (in thousands):

 

 

Purchase
Commitments

 

 

Other
Contractual
Commitments

 

 

Total

 

2025 (remaining six months)

 

$

1,797

 

 

$

648

 

 

$

2,445

 

2026

 

 

 

 

 

9

 

 

 

9

 

Total

 

$

1,797

 

 

$

657

 

 

$

2,454

 

 

Purchase commitments for inventories are highly dependent upon forecasts of customer demand. Due to the uncertainty in demand from its customers, the Company may have to change, reschedule, or cancel purchases or purchase orders from its suppliers. These changes may lead to vendor cancellation charges on these purchases or contractual commitments.

The following table summarizes the Company’s warranty accrual account activity during the three and six months ended June 30, 2025 and 2024:

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Balance at beginning of period

 

$

341

 

 

$

141

 

 

$

214

 

 

$

217

 

Charged (credited) to cost of revenue

 

 

(4

)

 

 

(15

)

 

 

123

 

 

 

(90

)

Recovery (cost) of warranty claims

 

 

(13

)

 

 

2

 

 

 

(13

)

 

 

1

 

Balance at end of period

 

$

324

 

 

$

128

 

 

$

324

 

 

$

128

 

 

The Company provides warranties on certain product sales for periods ranging from 12 to 36 months, and allowances for estimated warranty costs are recorded during the period of sale. The determination of such allowances requires the Company to make estimates of product return rates and expected costs to repair or to replace the products under warranty. The Company currently establishes warranty reserves based on historical warranty costs for each product line combined with liability estimates based on the prior 12 months’ sales activities. If actual return rates and/or repair and replacement costs differ significantly from the Company’s estimates, adjustments to recognize additional cost of sales may be required in future periods. Historically, the warranty accrual and the expense amounts have been immaterial.

18


 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This Item 2, Management’s Discussion and Analysis of Financial Condition and Results of Operations, and other parts of this Quarterly Report on Form 10-Q (“Quarterly Report”) contain forward-looking statements, within the meaning of the safe harbor provisions under Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that involve risks and uncertainties. Forward-looking statements reflect current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Forward-looking statements can also be identified by words such as “will,” “believe,” “could,” “should,” “would,” “may,” “anticipate,” “intend,” “plan,” “estimate,” “expect,” “project” or the negative of these terms or other similar expressions. Forward-looking statements are not guarantees of future performance and our actual results may differ significantly from the results discussed in the forward-looking statements. Factors that might cause such differences include, but are not limited to, those discussed in Part II, Item 1A of this Quarterly Report, and Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2024 under the heading “Risk Factors”. The following discussion should be read in conjunction with the audited consolidated financial statements and notes thereto included in Part II, Item 8 of our Annual Report on Form 10-K for the year ended December 31, 2024. We assume no obligation to revise or update any forward-looking statements for any reason, except as required by law.

Each of the terms the “Company,” “Identiv,” “we,” “us” and “our” as used herein refers collectively to Identiv, Inc. and its wholly-owned subsidiaries, unless otherwise stated.

Overview

Historically, we organized our operations into two reportable business segments: Identity and Premises. Our Identity segment included products and solutions that enabled secure access to information serving the logical access and cyber-security market, and protected connected objects and information using radio-frequency identification ("RFID") embedded security. Our Premises segment included the Company's solutions to address the premises security market for government and enterprise, including access control, video surveillance, analytics, audio, access readers and identities.

On September 6, 2024, we completed the sale of our Physical Security Business (as defined below), which historically represented our Premises segment, as well as our access card and identity reader operations, which were historically part of our Identity segment. As a result, we currently have one reportable segment: the IoT Business segment.

The IoT Business segment develops, manufactures, and supplies specialty Internet of Things ("IoT") solutions tailored for the healthcare industry and other high-value end markets. Our strategy is focused on developing highly engineered and specialized IoT inlays, tags, and labels for applications that provide significant value to our global customers. These specialty RFID IoT devices, including near field communication ("NFC"), high frequency ("HF"), dual frequency ("DF"), ultra-high frequency ("UHF") and Bluetooth Low Energy ("BLE") are attached to or embedded into physical items, such as syringes, pill containers, wine bottles, and sports jerseys, providing those items with a unique digital identity. These devices enable unique and secure digital interaction with the physical world while simultaneously capturing relevant data which can then be analyzed and managed by the end customer. We sell our products across multiple industries, focusing on pharmaceutical and medical devices, consumer electronics, mobile devices, wine and spirits, luxury goods, libraries, and logistics.

 

Closing of Asset Sale

On September 6, 2024, we completed the sale of our physical security, access card, and identity reader operations and assets, including all outstanding shares of Identiv Private Limited, our wholly-owned subsidiary (the “Physical Security Business”) to Hawk Acquisition, Inc., a Delaware corporation (“Buyer”) and a wholly-owned subsidiary of Vitaprotech SAS, a French société par actions simplifiée and provider of security solutions, and Buyer assumed certain of our liabilities related to the Physical Security Business (collectively, the “Asset Sale”) pursuant to that certain Stock and Asset Purchase Agreement, dated as of April 2, 2024, by and between the Company and Buyer. As consideration for the Asset Sale, we received approximately $143.9 million in cash. In connection with the closing of the Asset Sale, we entered into a transition services agreement (the “Transition Services Agreement”) with Buyer, which outlines the information technology, people, and facility support we will provide to Buyer for a period of 12 months to 18 months after the transaction closing date.

Following the completion of the Asset Sale, we continue to be a public company operating under the name Identiv, Inc. and continue to own the assets and liabilities of our business that were not sold to Buyer, which we refer to herein as the “IoT Business”. The discussion in this Item 2, Management’s Discussion and Analysis of Financial Condition and Results of Operations, unless otherwise noted, relates solely to our continuing operations.

19


 

Factors Affecting Our Performance

Market Adoption

Our financial performance depends on the pace, scope and depth of end-user adoption of our RFID products in multiple industries. That pace, scope and depth has resulted in large fluctuations in our operating results. For example, we have experienced lower unit sales of BLE transponder products to one of our customers undergoing a technology transition. We do not expect to resume shipments to this customer while they continue their technology transition. As a result, we have experienced a corresponding decrease in utilization in our production facilities in Southeast Asia.

We believe significant improvement in chip capabilities at lower costs has accelerated the opportunities for product engineers to integrate RFID into their products to create new and more engaging customer experiences, reduce counterfeiting, and ensure proper product use and adherence. Though we believe the number of opportunities for RFID-based solutions has increased, the evaluation period and customer adoption originally expected for certain applications have taken longer than we anticipated.

We believe the underlying, long-term trend is continued RFID adoption across multiple verticals, but regulated industries like healthcare take longer to optimize the technology and fully understand the benefits. We also believe that expanding use cases foster adoption across verticals and into other markets.

If RFID market adoption, and adoption of our products specifically, does not meet our expectations then our growth prospects and operating results will be adversely affected. If we are unable to meet end-user or customer volume or performance expectations, then our business prospects may be adversely affected. In contrast, if our RFID sales exceed expectations, then our revenue and profitability may be positively affected.

Given the uncertainties of the specific timing of our new customer deployments, we cannot assure you that we will have appropriate inventory and capacity levels or that we will not experience inventory shortfalls or overages in the future or acquire inventory at costs to maintain gross margins. We attempt to mitigate those risks by being deeply embedded in our customers’ design cycles, working with our chip partners on long lead time components, managing our limited capital equipment needs within a short cycle and future proofing our facilities to accommodate several scenarios for growth potential.

If end users with sizable projects change or delay them, we may experience significant fluctuation in revenue on a quarterly or annual basis, and we anticipate that uncertainty to continue to characterize our business for the foreseeable future.

RFID Device Production Transition

At the end of the second quarter of 2025, we completed the production of our RFID devices in our manufacturing facility in Singapore. Our customers have been requalified in our manufacturing facility in Thailand. As a result, we are maintaining and producing products from one location.

Focus on High-Margin Opportunities

To strengthen and grow our core channel business, we are prioritizing higher margin opportunities with existing customers and channel partners. Higher margin opportunities often involve complex devices as compared to standard specification products, and require a certain amount of customization for the customer. Increasing technological complexity often necessitates more development resources and longer evaluation periods to ensure the product meets customer needs. In choosing to prioritize higher margin opportunities, we have, and may continue to, decide not to support low-margin projects that may generate revenue. This could result in a negative impact on our operating results.

Competitive Landscape

We have seen a large increase in global production capacity at several of our RFID competitors. This has resulted in competitive pricing pressure, and, in response, we continue to exit some of our lowest margin business. This has had, and we expect will continue to have, a negative impact on our operating results.

 

Impacts of Macroeconomic Conditions and Other Factors on our Business

We conduct operations internationally with sales in the Americas, Europe and the Middle East, and Asia-Pacific regions. Our manufacturing operations and third-party contract manufacturers are in Southeast Asia. We purchase certain products and key components from a limited number of sources that depend on the supply chain, including freight, to receive components, transport finished goods and deliver our products across the world. In view of the rapidly changing business environment, we have experienced

20


 

delays and reductions in customer orders, shifting supply chain availability, component shortages, and other production-related challenges. We continue to monitor the global supply chain and its effect on our financial position, results of operations, and cash flows.

 

We have also recently been, and expect to continue to be, impacted by other adverse macroeconomic conditions, including but not limited to, inflation, foreign currency fluctuations, tariffs, global trade disruption, and the slowdown of economic activity around the globe. These conditions may also impact our customers, suppliers, contract manufacturers, logistics providers, and distributors, causing increases in cost of materials and higher shipping and transportation rates, which then impacts the pricing of our products. Price increases may not successfully offset cost increases or may cause us to lose market share and, in turn, may adversely impact our financial position, results of operations, and cash flows.

 

Effects of Asset Sale

Our business has and will continue to be affected by the Asset Sale. The Asset Sale included assets and operations that had historically represented the majority of our revenues, representing approximately 63% of our 2023 revenue, as well as a substantial portion of our assets, representing approximately 47% of our assets as of December 31, 2023. The gross margin profile of our continuing business has and will continue to be significantly lower than our historical total gross margins across a lower revenue base. As a result, we expect our loss from continuing operations to continue until we substantially increase our revenue to achieve scale.

For additional information regarding the risks related to our continuing business, see “Risks Related to Our Business, Products, and Industry” under “Risk Factors” in Part II, Item 1A in our Annual Report on Form 10-K for the year ended December 31, 2024.

Results of Operations

Our results of operations for the three and six months ended June 30, 2025 and 2024 are as follows (in thousands, except percentages).

 

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

2025

 

2024

 

%
Change

 

2025

 

2024

 

% Change

Net revenue

 

$5,040

 

$6,741

 

(25%)

 

$10,309

 

$13,399

 

(23%)

Gross profit (loss)

 

(474)

 

614

 

(177%)

 

(342)

 

1,097

 

(131%)

Gross profit (loss) margin

 

(9%)

 

9%

 

 

 

(3%)

 

8%

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

890

 

966

 

(8%)

 

1,677

 

1,863

 

(10%)

Selling and marketing

 

1,546

 

1,828

 

(15%)

 

2,953

 

2,997

 

(1%)

General and administrative

 

3,057

 

4,540

 

(33%)

 

6,203

 

8,020

 

(23%)

Restructuring and severance

 

420

 

 

100%

 

680

 

 

100%

Total operating expenses

 

5,913

 

7,334

 

(19%)

 

11,513

 

12,880

 

(11%)

Loss from continuing operations

 

(6,387)

 

(6,720)

 

 

 

(11,855)

 

(11,783)

 

 

Non-operating income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

Interest income (expense), net

 

1,320

 

(149)

 

N.M.

 

2,532

 

(236)

 

N.M.

Foreign currency losses, net

 

(870)

 

(59)

 

N.M.

 

(1,400)

 

(285)

 

391%

Loss from continuing operations before income tax benefit (provision)

 

(5,937)

 

(6,928)

 

 

 

(10,723)

 

(12,304)

 

 

Income tax benefit (provision)

 

(105)

 

5

 

N.M.

 

(108)

 

(1)

 

N.M.

Net loss from continuing operations

 

(6,042)

 

(6,923)

 

 

 

(10,831)

 

(12,305)

 

 

Income from discontinued operations, net of tax

 

 

707

 

(100%)

 

 

1,531

 

(100%)

Net loss

 

$(6,042)

 

$(6,216)

 

 

 

$(10,831)

 

$(10,774)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

N.M. - Not meaningful

 

 

 

 

 

 

 

 

 

 

 

 

 

21


 

Geographic net revenue based on each customer’s ship-to location is as follows (in thousands):

 

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

2025

 

2024

 

%
Change

 

2025

 

2024

 

% Change

Americas

 

$1,833

 

$3,386

 

(46%)

 

$4,071

 

$6,344

 

(36%)

Europe and the Middle East

 

1,964

 

2,068

 

(5%)

 

3,751

 

4,606

 

(19%)

Asia-Pacific

 

1,243

 

1,287

 

(3%)

 

2,487

 

2,449

 

2%

Total

 

$5,040

 

$6,741

 

 

 

$10,309

 

$13,399

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Percentage of net revenue:

 

 

 

 

 

 

 

 

 

 

 

 

Americas

 

36%

 

50%

 

 

 

39%

 

47%

 

 

Europe and the Middle East

 

39%

 

31%

 

 

 

36%

 

34%

 

 

Asia-Pacific

 

25%

 

19%

 

 

 

25%

 

19%

 

 

Total

 

100%

 

100%

 

 

 

100%

 

100%

 

 

Net Revenue

Net revenue for the three and six months ended June 30, 2025 was $5.0 million and $10.3 million, respectively, and decreased by $1.7 million and $3.1 million, respectively, compared with net revenue of $6.7 million and $13.4 million in the comparable periods of 2024. Net revenue in the Americas for three and six months ended June 30, 2025 decreased 46% and 36%, respectively, compared with the comparable periods of 2024. Net revenue in Europe, the Middle East, and the Asia-Pacific for three and six months ended June 30, 2025 was $3.2 million and $6.2 million, respectively, and decreased 4% and 12%, respectively, compared with $3.4 million and $7.1 million, respectively, in the comparable periods of 2024. The decrease was primarily due to lower unit sales of RFID transponder products as we exit low margin business opportunities, as well as reduced sales to our largest customer, who is working through safety stock they built up in 2024 in anticipation of transitioning production to Thailand.

Gross Profit (Loss) and Gross Margin

Gross profit (loss) for the three and six months ended June 30, 2025 was a gross loss of $474,000 and $342,000, respectively, compared with gross profit of $614,000 and $1.1 million, respectively, in the comparable periods of 2024. Gross profit represents net revenue less direct cost of product sales, manufacturing overhead, other costs directly related to preparing the product for sale including freight, scrap, and inventory adjustments, where applicable.

Gross profit (loss) margin for the three and six months ended June 30, 2025 decreased to gross loss margins of 9% and 3%, respectively, compared with gross profit margins of 9% and 8%, respectively, in the comparable periods of 2024. The decreases in gross profit margins were primarily attributable to incremental costs related to the transition of production to our Thailand facility and the dual manufacturing sites required during the transition, combined with underutilization of our manufacturing production facilities due to lower sales. In addition, we recorded a charge to cost of revenue of approximately $639,000 in the second quarter of 2025 related to the write-down of obsolete inventory at our Singapore production facility.

We expect there will be variation in our gross profit from period to period, as our gross profit has been and will continue to be affected primarily by varying mix among our products. Within each product category, gross margins have tended to be consistent, but over time may be affected by a variety of factors, including, without limitation, competition, product pricing, the volume of sales in any given quarter, manufacturing volumes, product configuration and mix, the availability of new products, product enhancements, risk of inventory write-downs and the cost and availability of components. At the end of the second quarter of 2025, we completed production of RFID transponder devices in our manufacturing facility in Singapore. We have requalified our customers in our Thailand production facility. Furthermore, in the fourth quarter of 2025, we expect to complete all shutdown activities associated with our Singapore facility. As a result of the elimination of fixed costs from our Singapore facility, we expect gross product margins to increase overall in the second half of 2025.

Operating Expenses

Information about our operating expenses for the three and six months ended June 30, 2025 and 2024 is set forth below (dollars in thousands).

Research and Development

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2025

 

 

2024

 

 

% Change

 

 

2025

 

 

2024

 

 

% Change

 

Research and development

 

$

890

 

 

$

966

 

 

 

(8

%)

 

$

1,677

 

 

$

1,863

 

 

 

(10

%)

as a % of net revenue

 

 

18

%

 

 

14

%

 

 

 

 

 

16

%

 

 

14

%

 

 

 

 

22


 

 

Research and development expenses consist primarily of employee compensation and fees for the development of hardware, software and firmware products. The majority of our research and development activities focused on the continued development of existing products and the development of new offerings for emerging market opportunities.

Research and development expenses for the three and six months ended June 30, 2025 decreased in dollars compared to the comparable prior year periods primarily due to lower external services costs, as well as lower prototype related costs but increased as a percentage of revenue due to lower revenue levels.

Selling and Marketing

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2025

 

 

2024

 

 

% Change

 

 

2025

 

 

2024

 

 

% Change

 

Selling and marketing

 

$

1,546

 

 

$

1,828

 

 

 

(15

%)

 

$

2,953

 

 

$

2,997

 

 

 

(1

%)

as a % of net revenue

 

 

31

%

 

 

27

%

 

 

 

 

 

29

%

 

 

22

%

 

 

 

 

Selling and marketing expenses consist primarily of employee compensation as well as customer lead generation activities, tradeshow participation, advertising and other marketing and selling costs.

Selling and marketing expenses for the three and six months ended June 30, 2025 decreased in dollars compared to the comparable periods in 2024 primarily due to lower stock-based compensation expense, lower advertising, trade show and travel related costs but increased as a percentage of revenue due to lower revenue levels.

General and Administrative

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2025

 

 

2024

 

 

% Change

 

 

2025

 

 

2024

 

 

% Change

 

General and administrative

 

$

3,057

 

 

$

4,540

 

 

 

(33

%)

 

$

6,203

 

 

$

8,020

 

 

 

(23

%)

as a % of net revenue

 

 

61

%

 

 

67

%

 

 

 

 

 

60

%

 

 

60

%

 

 

 

 

General and administrative expenses consist primarily of compensation expenses for employees performing administrative functions, and professional fees incurred for legal, auditing and other consulting services.

General and administrative expenses for the three months ended June 30, 2025 decreased compared to the comparable period in 2024 primarily due to strategic review-related costs incurred in 2024 of $1.6 million related to the Asset Sale in 2024 that did not recur in 2025. The dollar decrease in general and administrative expenses for the six months ended June 30, 2025 compared to the prior year period was due to strategic review-related costs of $2.6 million, partially offset by higher stock-based compensation expense in 2025.

Restructuring and Severance

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2025

 

 

2024

 

 

% Change

 

 

2025

 

 

2024

 

 

% Change

 

Restructuring and severance

 

$

420

 

 

$

 

 

 

100

%

 

$

680

 

 

$

 

 

 

100

%

Restructuring expenses for the three and six months ended June 30, 2025 consist of severance costs of $312,000 and $334,000, respectively, and impairments of an operating lease right-of-use asset of $108,000 and $346,000, respectively, primarily associated with shutdown related activities and vacated production space at the Company's Singapore manufacturing facility.

Non-operating Income (Expense)

Information about our non-operating income (expense) for the three and six months ended June 30, 2025 and 2024 is set forth below (dollars in thousands).

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

 

2025

 

 

2024

 

 

% Change

 

2025

 

 

2024

 

 

% Change

 

Interest income (expense), net

 

$

1,320

 

 

$

(149

)

 

N.M.

 

$

2,532

 

 

$

(236

)

 

N.M.

 

Foreign currency losses, net

 

$

(870

)

 

$

(59

)

 

N.M.

 

$

(1,400

)

 

$

(285

)

 

 

391

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

N.M. - Not meaningful

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

23


 

Interest income (expense), net consists of interest income generated on our cash equivalents net of interest costs on our financial liabilities and amortization of debt issuance costs. The increase in interest income (expense), net for the three and six months ended June 30, 2025 compared to the comparable period of 2024 was primarily attributable to interest earned on our money market accounts and treasury bills.

Changes in currency valuation in the periods mainly were the result of exchange rate movements between the U.S. Dollar, the Euro and the Thai Baht. Our foreign currency gains and losses primarily result from the valuation of current assets and liabilities denominated in a currency other than the functional currency of the respective entity in the local financial statements.

Income Tax Provision

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

2025

 

 

2024

 

 

% Change

 

2025

 

 

2024

 

 

% Change

Income tax benefit (provision)

 

$

(105

)

 

$

5

 

 

N.M.

 

$

(108

)

 

$

(1

)

 

N.M.

Effective tax rate

 

 

(2

%)

 

(0%)

 

 

 

 

 

(1

%)

 

 

(0

%)

 

 

 

As of June 30, 2025, our deferred tax assets are fully offset by a valuation allowance. ASC 740, Income Taxes, provides for the recognition of deferred tax assets if realization of such assets is more likely than not. Based upon the weight of available evidence, which includes historical operating performance, reported cumulative net losses since inception and difficulty in accurately forecasting our future results, we provided a full valuation allowance against all of our net U.S. and foreign deferred tax assets. We reassess the need for our valuation allowance on a quarterly basis. If it is later determined that a portion or all of the valuation allowance is not required, it generally will be a benefit to the income tax provision in the period such determination is made.

We recorded an income tax provision during the three and six months ended June 30, 2025, respectively, associated primarily with withholding taxes on interest income earned on cash equivalents at one of our foreign subsidiaries. The effective tax rates for the three and six months ended June 30, 2025 and 2024 differ from the federal statutory rate of 21% primarily due to a change in valuation allowance, and the provision or benefit in certain foreign jurisdictions, which are subject to higher tax rates.

Income from Discontinued Operations, net of tax

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2025

 

 

2024

 

 

% Change

 

 

2025

 

 

2024

 

 

% Change

 

Income from discontinued operations, net of tax

 

$

 

 

$

707

 

 

 

(100

%)

 

$

 

 

$

1,531

 

 

 

(100

%)

Income from discontinued operations consists of the results of operations, net of tax, of our Physical Security Business which we disclosed as discontinued operations. See Note 3, Discontinued Operations.

Liquidity and Capital Resources

As of June 30, 2025, our working capital, defined as current assets less current liabilities, was $137.5 million, a decrease of $7.4 million compared to $144.9 million as of December 31, 2024. As of June 30, 2025, our cash and cash equivalents balance was $129.3 million.

On November 7, 2024, we announced that our board of directors authorized a stock repurchase program (the “Stock Repurchase Program”). Under the Stock Repurchase Program, effective November 15, 2024, we may repurchase up to $10 million of shares of common stock on a discretionary basis from time to time through open market repurchases, privately negotiated transactions, or other means. The timing and amount of shares repurchased depends on a number of factors, including stock price, trading volume, general market and business conditions, liquidity and capital needs, and other factors. The Stock Repurchase Program does not obligate us to repurchase any specific dollar amount or acquire any specific number of shares of common stock. The Stock Repurchase Program has no expiration date and may be suspended or discontinued at any time without notice. As of June 30, 2025, we have repurchased a total of 463,779 shares of common stock under the Stock Repurchase Program for total consideration of approximately $1.9 million. During the three and six months ended June 30, 2025, there were no repurchases of shares of common stock under the Stock Repurchase Program.

24


 

As our previously unremitted earnings have been subjected to U.S. federal income tax, we expect any repatriation of these earnings to the U.S. would not incur significant additional taxes related to such amounts. However, our estimates are provisional and subject to further analysis. Generally, most of our foreign subsidiaries have accumulated deficits and cash and cash equivalents that are held outside the United States are typically not cash generated from earnings that would be subject to tax upon repatriation if transferred to the United States. We have access to the cash held outside the United States to fund domestic operations and obligations without any material income tax consequences. As of June 30, 2025, the amount of cash included at such subsidiaries was $13.7 million. We have not, nor do we anticipate the need to, repatriate funds to the United States to satisfy domestic liquidity needs arising in the ordinary course of business.

We have historically incurred operating losses and negative cash flows from operating activities, and we expect to continue to incur losses in the future. As of June 30, 2025, we had an accumulated deficit of $350.9 million. During the six months ended June 30, 2025, we had a loss from continuing operations of $10.8 million.

We believe our existing cash and cash equivalents, together with cash generated from operations, will be sufficient to satisfy our working capital needs to fund operations for the next twelve months and beyond. We may also use cash to acquire or invest in complementary businesses, technologies, services or products that would change our cash requirements. We may also choose to finance our business through public or private equity offerings, debt financings or other arrangements. However, there can be no assurance that additional capital will be available to us or that such capital will be available to us on acceptable terms. If we raise funds by issuing equity securities, dilution to stockholders could result. Debt or any equity securities issued also may provide for rights, preferences or privileges senior to those of holders of our common stock. The terms of debt securities issued or borrowings could impose significant restrictions on our operations. The incurrence of additional indebtedness or the issuance of certain debt or equity securities could result in increased fixed payment obligations and could also result in restrictive covenants, such as limitations on our ability to incur additional debt or issue additional equity, limitations on our ability to acquire or license intellectual property rights and other operating restrictions that could adversely affect our ability to conduct our business. In addition, the issuance of additional equity securities by us, or the possibility of such issuance, may cause the market price of our common stock to decline. If we are not able to secure additional funding when needed, we may have to curtail or reduce the scope of our business or forgo potential business opportunities.

The following summarizes our cash flows for the six months ended June 30, 2025 and 2024 (in thousands):

 

 

 

Six Months Ended June 30,

 

 

 

2025

 

 

2024

 

Net cash used in operating activities

 

$

(6,848

)

 

$

(2,294

)

Net cash used in investing activities

 

 

(553

)

 

 

(367

)

Net cash used in financing activities

 

 

(354

)

 

 

(2,654

)

Effect of exchange rates on cash, cash equivalents, and restricted cash

 

 

1,448

 

 

 

(68

)

Net decrease in cash, cash equivalents, and restricted cash

 

 

(6,307

)

 

 

(5,383

)

Cash, cash equivalents, and restricted cash at beginning of period

 

 

135,946

 

 

 

24,384

 

Cash, cash equivalents, and restricted cash at end of period

 

$

129,639

 

 

$

19,001

 

Cash flows from operating activities

Cash used in operating activities for the six months ended June 30, 2025 of $6.8 million was primarily due to a net loss of $10.8 million, partially offset by an increase in cash from net changes in operating assets and liabilities of $647,000 and adjustments to net loss for certain non-cash items of $3.3 million, consisting of depreciation, amortization, stock-based compensation, and impairment of operating lease right-of-use asset.

Cash used in operating activities for the six months ended June 30, 2024 of $2.3 million was primarily due to net loss of $10.8 million, partially offset by an increase in cash from net changes in operating assets and liabilities of $3.9 million and adjustments for certain non-cash items of $4.6 million, consisting primarily of depreciation, amortization and stock-based compensation.

Cash flows from investing activities

Cash used in investing activities for the six months ended June 30, 2025 and 2024 was $553,000 and $367,000, respectively, which related to capital expenditures for our manufacturing facility in Thailand.

Cash flows from financing activities

Cash used in financing activities during the six months ended June 30, 2025 was $354,000 which related to taxes paid related to net share settlements of RSUs.

25


 

Cash used in financing activities during the six months ended June 30, 2024 was $2.7 million, which consisted of net borrowings of $9.9 million offset by repayments of $12.0 million under our revolving loan facility, and taxes paid related to net share settlements of RSUs of $541,000.

Contractual Obligations

We lease facilities, certain equipment, and automobiles under non-cancelable operating lease agreements. See Note 13, Leases, in the accompanying notes to our condensed consolidated financial statements.

Purchases for inventories are highly dependent upon forecasts of customer demand. Due to the uncertainty in demand from our customers, we may have to change, reschedule, or cancel purchases or purchase orders from our suppliers. These changes may lead to vendor cancellation charges on these orders or contractual commitments. See Note 14, Commitments and Contingencies, in the accompanying notes to our condensed consolidated financial statements.

Our other long-term liabilities include gross unrecognized tax benefits, and related interest and penalties. At this time, we are unable to make a reasonably reliable estimate of the timing of payments in individual years in connection with these tax liabilities.

Off-Balance Sheet Arrangements

We have not entered into off-balance sheet arrangements, or issued guarantees to third parties.

Climate Change

We believe that neither climate change, nor governmental regulations related to climate change, have had a material effect on our business, financial condition or results of operations.

Critical Accounting Estimates

Our condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these condensed consolidated financial statements requires management to establish accounting policies that contain estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. These policies relate to revenue recognition, inventory, income taxes, long-lived assets, and stock-based compensation. We have other important accounting policies and practices; however, once adopted, these other policies either generally do not require us to make significant estimates or assumptions or otherwise only require implementation of the adopted policy and not a judgment as to the policy itself. Management bases its estimates and judgments on historical experience and on various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Despite our intention to establish accurate estimates and assumptions, actual results may differ from these estimates under different assumptions or conditions.

During the three months ended June 30, 2025, management believes there have been no significant changes to the items that we disclosed within our critical accounting policies and estimates in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2024.

Recent Accounting Pronouncements

See Note 2, Significant Accounting Policies and Recent Accounting Pronouncements, in the accompanying notes to our unaudited condensed consolidated financial statements in Item 1 of Part I of this Quarterly Report for a description of recent accounting pronouncements, which is incorporated herein by reference.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Not applicable.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

26


 

We maintain “disclosure controls and procedures,” as such term is defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, or Exchange Act, that are designed to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, management recognized that disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Our disclosure controls and procedures have been designed to meet reasonable assurance standards. Additionally, in designing disclosure controls and procedures, our management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures. The design of any disclosure controls and procedures also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Based on their evaluation as of the end of the period covered by this Quarterly Report on Form 10-Q, our Chief Executive Officer and Chief Financial Officer have concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.

Changes in Internal Controls over Financial Reporting

We have made no changes to our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) during the three months ended June 30, 2025, that have materially affected, or that are reasonably likely to materially affect, our internal control over financial reporting.

27


 

PART II. OTHER INFORMATION

We are and from time to time, may become subject to various legal proceedings and claims arising in the ordinary course of business or could be named a defendant in other lawsuits. Legal proceedings could result in material costs, occupy significant management resources and entail penalties, even if we prevail. The outcome of such claims or other proceedings cannot be predicted with certainty and may have a material effect on our financial condition, results of operations or cash flows.

Item 1A. Risk Factors

Our business and results of operations are subject to numerous risks, uncertainties, and other factors that you should be aware of. You should carefully review and consider the information regarding certain factors that could materially affect our business, financial condition or future results set forth below and in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 under the heading “Risk Factors”. There have been no material changes from the risk factors disclosed in our 2024 Annual Report on Form 10-K other than as set forth below. The risks, uncertainties and other factors described in the risk factors are not the only ones facing our company. Additional risks, uncertainties and other factors not presently known to us or that we currently deem immaterial may also impair our business operations. Any of the risks, uncertainties and other factors could have a materially adverse effect on our business, financial condition, results of operations, cash flows or product market share and could cause the trading price of our common stock to decline substantially.

Changes in U.S. trade policy and the impact of tariffs may have a material adverse effect on our business and results of operations.

Our business, financial condition and results of operations may be adversely affected by uncertainty and changes in U.S. trade policies, including tariffs, trade agreements or other trade restrictions imposed by the U.S. or other governments. For example, the U.S. government has recently announced or implemented changes to its trade policy, including increasing tariffs on imports, in some cases significantly. Several of these recent tariff actions have been followed by announcements of limited exemptions, temporary pauses, and retaliatory measures against certain U.S. imports.

As of July 1, 2025, approximately 25% of our business is exposed to U. S. tariffs due to our manufacturing in Thailand. On July 31, the White House announced a 19% tariff on imports from Thailand. The imposition of or increase in tariffs applicable to us, including reciprocal tariffs, will increase the cost of importing our products. This would in turn increase our costs unless we are able to implement actions to offset these costs, such as leveraging tariff exemptions where possible, taking actions to optimize our supply chain or source from alternative suppliers, or increasing our prices. While we have developed a pass-through strategy intended to protect margins, the amount of Thailand-origin components required to obtain a valid certificate of origin remains uncertain, particularly in light of recent U.S. enforcement efforts aimed at preventing transshipment. In the event our products are determined to be transshipments, they would be subject to higher tariffs. There can be no assurance that our efforts will be successful or that we will be able to successfully offset or mitigate the resulting increase in our costs. If we are unable to pass on any cost increases or if supply and demand conditions will not support price increases for our products, our revenue and gross margin would be negatively impacted. In addition, retaliatory actions by other countries in response to U.S. trade policy could increase prices for our products and could negatively affect demand for our products.

Tariffs or other trade restrictions may also lead to increased costs for our customers, declining consumer confidence, significant inflation and diminished expectations for the economy, as well as reduced demand for our products. Such conditions could have a material adverse impact on our business, results of operations and cash flows. In addition, tariff actions by the U.S. and retaliatory actions by other countries have caused and may in the future cause significant disruption and volatility in the financial markets, which could adversely affect the availability, terms and cost of capital, which in turn could increase our costs of capital and limit our access to external financing sources.

Changes in tariffs and trade restrictions can be announced with little or no advance notice. The adoption and expansion of tariffs or other trade restrictions, increasing trade tensions, or other changes in governmental policies related to tariffs, trade agreements or trade policies are difficult to predict, which makes risks difficult to anticipate and mitigate. If we are unable to navigate further changes in U.S. or international trade policy, it could have a material adverse impact on our business, financial condition and results of operations.

28


 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

During the three months ended June 30, 2025, we repurchased 58,324 shares of our common stock surrendered to the Company to satisfy tax withholding obligations in connection with the vesting of RSUs issued to employees. There were no repurchases under the Stock Repurchase Program during the three months ended June 30, 2025.

The table below sets forth information regarding the Company’s purchases of its common stock during the three months ended June 30, 2025:

 

 

Issuer Purchases of Equity Securities

 

Period

 

Total number of shares purchased(1)

 

 

Average price paid per share

 

 

Total number of shares purchased as part of publicly announced plans or programs

 

 

Maximum number (or approximate dollar value) of shares that may yet be purchased under the plans or programs

 

April 1, 2025 – April 30, 2025

 

 

44,878

 

 

$

3.16

 

 

 

 

 

 

 

May 1, 2025 – May 31, 2025

 

 

798

 

 

 

3.34

 

 

 

 

 

 

 

June 1, 2025 – June 30, 2025

 

 

12,648

 

 

 

3.27

 

 

 

 

 

 

 

Total

 

 

58,324

 

 

$

3.19

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Consists of shares surrendered to the Company to satisfy tax withholding obligations in connection with the vesting of RSUs issued to employees.

 

 

Item 5. Other Information

 

Rule 10b5-1 and Non-Rule 10b5-1 Trading Arrangements

During the quarter ended June 30, 2025, no director or officer adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

29


 

Item 6. Exhibits

 

Exhibit

Number

 

Description

 

 

 

  3.1

 

Restated Certificate of Incorporation of Identiv, Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on June 13, 2025).

 

 

 

  3.2^

 

Amended and Restated Bylaws of Identiv, Inc., as amended June 10, 2025

 

 

 

  31.1^

Certification of Chief Executive Officer pursuant to Section 302 of the Securities Exchange Act of 1934.

 

 

 

  31.2^

Certification of Chief Financial Officer pursuant to Section 302 of the Securities Exchange Act of 1934.

 

 

 

  32#

Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

101.INS

Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.

 

 

 

101.SCH

Inline XBRL Taxonomy Extension Schema Document with embedded Linkbase Documents.

 

 

 

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

 

^ Filed herewith.

# Furnished herewith and not “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certifications will not be deemed to be incorporated by reference into any filings under the Securities Act of 1933 or the Exchange Act, except to the extent that the registrant specifically incorporates them by reference.

 

30


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

IDENTIV, INC.

 

 

 

 

 

August 8, 2025

By:

/S/ Kirsten Newquist

Kirsten Newquist

Chief Executive Officer

(Principal Executive Officer)

 

 

 

 

 

August 8, 2025

By:

/S/ Ed Kirnbauer

Ed Kirnbauer

Chief Financial Officer and Secretary

(Principal Financial and Accounting Officer)

 

31